Michael D Hughes Selected Research

cilgavimab and tixagevimab drug combination

12/2022

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael D Hughes Research Topics

Disease

28	COVID-19 05/2024 - 12/2021
18	Acquired Immunodeficiency Syndrome (AIDS) 12/2023 - 06/2002
13	Infections 10/2023 - 06/2002
12	HIV Infections (HIV Infection) 01/2021 - 05/2002
9	Disease Progression 05/2024 - 11/2003
6	Tuberculosis (Tuberculoses) 05/2024 - 01/2020
4	Anemia 03/2023 - 04/2011
4	Viremia 01/2023 - 07/2012
3	Birth Weight (Birth Weights) 03/2023 - 05/2002
3	Weight Gain 01/2019 - 07/2013
2	Virus Diseases (Viral Diseases) 04/2024 - 09/2023
2	Premature Birth (Birth, Premature) 03/2023 - 06/2002
2	Iron Deficiencies 03/2023 - 01/2023
2	Malaria 03/2023 - 02/2012
2	Stillbirth 03/2023 - 06/2002
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2023 - 01/2020
2	Inflammation (Inflammations) 01/2023 - 01/2014
2	Insulin Resistance 09/2021 - 07/2008
2	Atherosclerosis 01/2021 - 07/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2014
2	Human Influenza (Influenza) 01/2020 - 12/2017
2	Neutropenia 01/2018 - 01/2013
2	Hepatitis C 01/2018 - 02/2013
2	Hepatitis 01/2018 - 04/2012
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 03/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	Type 2 Diabetes Mellitus (MODY) 09/2021
1	Diarrhea 01/2020
1	Pneumonia (Pneumonitis) 01/2020

Drug/Important Bio-Agent (IBA)

14	Monoclonal AntibodiesIBA 05/2024 - 12/2021
14	RNA (Ribonucleic Acid)IBA 10/2023 - 06/2005
11	Antiviral Agents (Antivirals)IBA 05/2024 - 12/2017
7	bamlanivimabIBA 11/2023 - 12/2021
6	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 06/2002
5	Rifampin (Rifampicin)FDA LinkGeneric 05/2024 - 01/2020
5	Nevirapine (Viramune)FDA Link 10/2019 - 10/2010
5	vicrivirocIBA 08/2010 - 07/2007
4	IronIBA 03/2023 - 04/2011
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2008
4	Tenofovir (Viread)FDA Link 10/2019 - 05/2014
4	Ritonavir (Norvir)FDA Link 01/2018 - 02/2012
4	Zidovudine (Retrovir)FDA LinkGeneric 09/2015 - 06/2002
3	Interferon-gamma (Interferon, gamma)IBA 01/2023 - 01/2020
3	octaneIBA 10/2019 - 04/2012
3	Lopinavir FDA Link 01/2018 - 02/2012
3	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2018 - 01/2013
3	Reverse Transcriptase InhibitorsIBA 01/2018 - 05/2007
2	amubarvimabIBA 05/2024 - 01/2023
2	romlusevimabIBA 05/2024 - 01/2023
2	Viral RNAIBA 10/2023 - 08/2022
2	Ferritins (Ferritin)IBA 03/2023 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 03/2023 - 02/2013
2	tixagevimabIBA 01/2023 - 12/2022
2	VaccinesIBA 01/2023 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2023 - 12/2022
2	cilgavimabIBA 01/2023 - 12/2022
2	nirmatrelvir and ritonavir drug combinationIBA 01/2023 - 08/2022
2	AntigensIBA 12/2021 - 03/2009
2	Insulin (Novolin)FDA Link 09/2021 - 07/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2009
2	Oseltamivir (Tamiflu)FDA Link 01/2020 - 12/2017
2	Emtricitabine (Emtriva)FDA Link 10/2019 - 09/2015
2	SofosbuvirIBA 01/2019 - 01/2018
2	sofosbuvir drug combination ledipasvirIBA 01/2019 - 01/2018
2	InterleukinsIBA 01/2019 - 02/2004
2	Alanine Transaminase (SGPT)IBA 01/2018 - 02/2013
2	efavirenz (Sustiva)FDA Link 09/2015 - 04/2011
2	Lamivudine (Epivir)FDA Link 09/2015 - 06/2002
2	CreatinineIBA 05/2014 - 02/2013
2	NucleosidesIBA 05/2007 - 06/2002
1	dolutegravirIBA 05/2024
1	ogalvibartIBA 01/2024
1	crexavibartIBA 01/2024
1	Messenger RNA (mRNA)IBA 11/2023
1	EpitopesIBA 11/2023
1	Therapeutic UsesIBA 11/2023
1	Neutralizing AntibodiesIBA 10/2023
1	camostatIBA 10/2023
1	Isoniazid (Ftivazide)FDA LinkGeneric 09/2023
1	N-nitrosoiminodiacetic acidIBA 03/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Dietary IronIBA 01/2023
1	PlacebosIBA 01/2023
1	SAB-185IBA 01/2023
1	cilgavimab and tixagevimab drug combinationIBA 12/2022
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2022
1	Nucleic AcidsIBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 09/2021
1	EndotoxinsIBA 09/2021
1	Inulin FDA Link 09/2021
1	PrebioticsIBA 09/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Tuberculin (PPD)IBA 01/2020

Therapy/Procedure

30	Therapeutics 04/2024 - 05/2002
9	Highly Active Antiretroviral Therapy (HAART) 01/2023 - 06/2002
7	Art Therapy 09/2023 - 02/2012
1	Intravenous Administration 01/2024
1	Contraception (Birth Control) 12/2023
1	Aftercare (After-Treatment) 01/2023
1	Investigational Therapies (Experimental Therapy) 11/2022